Florida Society of Clinical Oncology: Florida Society of Clinical Oncology: The Voice of Oncology in FloridaThe Voice of Oncology in Florida

FLASCOFLASCO

20172017––2018 2018 LeadershipLeadership

Richard McDonough MD

President

Luis Raez MD

Vice President

Barry Berman MD

Secretary

Hank Hill MD

Treasurer

Michael Diaz MD

Immediate Past President

Syed Abid MD Al-Hazzouri MD

Sikander Ailawadhi MD Gary Bowers MD

Delmarie Butler RN CBHN BSHSA CNBNN

Robert Cassell MD PhD Melody Chang RPh

Chakra Chaulagain MD FACP Gerardo Colon-Otero MD

Jose Davila MD Mary Dean MD

Aaron Denson MD Craig Deligdish MD

Dina Dumercy PharmD BCOP Ana Espinosa DNP MBA RN OCN

Steven Fein MD Karen Fields MD

Laura Freedman MD Jorge J. Garcia PharmD

Thomas George MD FACP Shelly Glenn

Terry Gruchow PAC Lucio Gordan MD

Ardeshir Hakam MD William Harrer MD

Eric Harris DO Randal Henderson MD MBA

John Hiemenz MD Maen Hussein MD

Mohammad Jahanzeb MD Kun Jiang MD

Sachin Kamath MD Waseem Khan MD Jeanelle King PAC

Kapisthalam Kumar MD Richard Levine MD

Mayra Lima MSN ARNP FNPC Loretta Loftus MD MBA

Shannon Luker RN OCN CBCN Reshma Mahtani DO

Merry Jennifer Markham MD Alan Marks MD

Shahla Masood MD Tarek Mekhail MD

Joseph Mignone MD Arjun Mittra MD MBBS

Daniel Morris MD Pareshkumar Patel MD

Brendan Prendergast MD Luis Raez MD

Brian Ramnaraign MD Joseph Rosenblatt MD Edgardo Santos MD

Shalin Shah DO Jason Starr DO

Winston Tan MD Scott Tetreault MD Beau Toskich MD

Gene Wetzstein, PharmD, BCOP, CPh Teri Valls

Magali Van den Bergh MD Jonathan Zager, MD Dorothy Phillips

Executive Director

C ourse Description: The Florida Society of Clinical Oncology is hosting a two day meeting designed for medical oncologists, hematologists, radiation

oncologists, surgical oncology, pathologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents, and fellows that manage heath care for cancer patients. This conference will provide an emphasis on multidisciplinary collaboration among all professional health care teams with dynamic educational tracks that focus on specific driven topics addressing the current and future changes in the landscape of cancer care.

The 2017 Fall meeting will center on the multi-disciplinary presentations and case studies in AML, Myeloma, and CNS which include the collaboration of top clinicians, as well as up-to-date information on Healthcare Disparities. Additional sessions include information on hot topics in nursing, patient navigation, pharmacy, and administration.

FLASCO 2017 FALL SESSION October 20-21, 2017

Renaissance Orlando at Sea World 6677 Harbor Drive │ Orlando, Florida 32821

FLASCO 40th ANNIVERSARY CELEBRATION

Join us Friday evening to help us

celebrate 40 years of FLASCO

history from the perspective of

Oncology Advancements, featuring

ASCO CEO, Dr. Clifford Hudis

and many Past FLASCO

Presidents!

FLASCO Fall Session Features Four Educational Tracks

Multi-

Disciplinary Pharmacy Administrator

Nursing/

Navigator

“Oncology Disparities”

Key Note Speaker:

Harold P. Freeman, MD President and CEO Harold P. Freeman Patient Navigation Institute New York City, New York

Friday, October 20, 2017

4:30–6:00pm Poster Presentations

6:00 – 7:30 pm Reception/Visit Exhibits/Cash Bar Available

7:30 – 9:30 pm Dinner & Program

Celebrate FLASCO 40th Anniversary

40 Years of Advances in Cancer Care—Clifford Hudis, MD, ASCO CEO

Saturday, October 21, 2017

6:30-8:00am Registration/Breakfast/Visit Exhibitors

8:00–8:30am Opening Remarks & Supporter Recognition

8:30–9:30am Oncology Disparity—Harold P. Freeman, MD, President and CEO

Harold P. Freeman Patient Navigation Institute, New York, New York

9:30–10:15am Break/Visit Exhibitors

10:15–11:45am

Multi-Disciplinary Pharmacy Nursing/ Navigator Administrator

Multiple Myeloma & AML

ACADEMIC ONCOLOGY (AML) Justin Watts, MD University of Miami

BONE MARROW TRANSPLANT Hugo F. Fernandez, MD Moffitt Cancer Center

COMMUNITY ONCOLOGY Steven Fein, MD Miami Cancer Institute

HEMATOLOGY PATHOLOGY Elizabeth Sagatys, MD Moffitt Cancer Center

ACADEMIC ONCOLOGY (Multiple Myeloma) Sergio Giralt, MD Memorial Sloan Kettering Cancer Center

CASE STUDY (AML) Daniel Kerr, MD, PhD Moffitt Cancer Center

CASE STUDY (Multiple Myeloma) Abdullah Khan, MD University of Miami

Clinical Considerations of Herbal Product

Utilization within the Oncology Patient

Population

Jessica Unzaga, PharmD, BCPS Memorial Healthcare System

Ashwin Mehta, MD

Memorial Healthcare System

Breast Cancer Case Studies BREAST NAVIGATOR

Cara Kondaki, MSW Cleveland Clinic

PHARMACIST Katerine Dumais, PharmD, MPH Memorial Cancer Institute

NURSE PRACTITIONER Deborah Hawkins, ARNP Florida Cancer Specialists

REHABILITATION PHYSICIAN Amber Searcy, DPT, CLT Good Samaritan Medical

SOCIAL WORKER Victoria Peterson, Moffitt Cancer Center

CLINICAL RESEARCH NURSE Cheryl Habaue,MSN, RN, CCRP Cleveland Clinic Florida

NUTRITIONIST Amanda Amigo, LD Cleveland Clinic Florida

GENETICS NURSE PRACTITIONER Conni Murphy, ARNP, RNC Good Samaritan Breast Institute

10:15-11:00 AM Multi-Faceted Oncology

Management Kevin Mays, EdD Mays Leadership Group

**************

11:00-11:45 AM Discussion Panel

SMALL PRACTICE Shelli Johnson Cancer Care Centers of Brevard

LARGE PRACTICE Inga Gonzalez Florida Cancer Specialists

HOSPITAL BASED Maggie Wiegandt Memorial Healthcare System

ACADEMIC CENTER TBD

11:45–12:45pm Lunch/Networking

12:45 –

2:15pm

Multi-Disciplinary Pharmacy Nursing/ Navigator Administrators

CNS NEURO-ONCOLOGY

Herbert Newton, MD Florida Hospital

NEURO-SURGERY Dr. Ronald Reimer Mayo Clinic Florida

NEURO-RADIOLOGY Dr. Vivek Gupta Mayo Clinic Florida

RADIATION-ONCOLOGY Dr. Naren Ramakrishna Orlando Health

NEURO-PATHOLOGY Dr. Robert Macaulay Moffitt Cancer Center

CASE STUDY Sonikpreet, MD Mayo Florida Fellow

12:45PM - 1:45PM The Immune System

Strikes Back; Revenge of the T-cell: The Saga of

Chimeric Antigen Receptor T-Cell Therapy Christina Bachmeier,

PharmD, BCOP Moffitt Cancer Center

**********

2:00PM - 3:00PM Going Beyond the Standard of Care:

Translation of Personalized Medicine

into the Clinical Oncology Setting

Christine M. Walko, PharmD, BCOP Moffitt Cancer Center

12:45PM - 1:45PM Precision Medicine and

Molecular Testing David Sallman, MD

Moffitt Cancer Center

**********

2:00PM - 3:00PM Cancer Diagnosis and

Financial Toxicity Elaine Towle, CMPE

American Society of Clinical Oncology (ASCO)

Transition to Integrating Value-Based Care into

Fee-For-Service

NAVIGATION Lisa Eusebio, RN, BSN Memorial Healthcare System

SURVIVORSHIP Kena C. Miller, RN, MSN, ARNP-BC Takeda Oncology

COORDINATION OF CARE Beth Wittmer Florida Cancer Specialists

WORKFLOW QUALITY MEASURES Sierra Tomlinson Florida Cancer Specialists

2:15 – 3:00 pm Interventional Oncology

Beau Toskich, MD Mayo Clinic Florida

3:00 pm Closing Remarks

Upon completion of the conference you will be able to:

1. Discuss new treatment options of multiple myeloma, AML, and CNS giving the different

perspectives of multi-disciplinary physicians.

2. Learn the new technology of interventional oncology.

3. Explain the importance of CAR-T, the benefits of herbal product utilization, and what

personalized medicine means to the clinical oncology setting.

4. Share the different perspectives of treatment and care of breast cancer case studies from

the expertise of many oncology professionals.

5. Learn organizational skills from a professional Oncology Management Coach.

CONFERENCE OBJECTIVES

Page 3 of 4Page 3 of 4 FLASCO CONFERENCE GOAL FLASCO CONFERENCE GOAL is to continue to develop a comprehensive

range of programs that emphasize the latest developments, state-of-the-art information

and enhanced educational strategies for the intra-professional team.

CONFERENCE OUTCOME MEASURES:CONFERENCE OUTCOME MEASURES:

Participants should be able to apply the knowledge acquired during this Participants should be able to apply the knowledge acquired during this

conference to improve their competence, performance, and/or patient outcomes conference to improve their competence, performance, and/or patient outcomes

in the daily treatment of their patients. To measure attendees perceptions of in the daily treatment of their patients. To measure attendees perceptions of

these gains, they will complete an evaluation form at the end of the conference.these gains, they will complete an evaluation form at the end of the conference.

ACCREDITATION STATEMENTS Physicians: The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

FLASCO has applied to the Medical Educator Consortium to approve this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical Educator Consortium and Florida Society of Clinical Oncology. The Medical Educator Consortium is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure Statement:

The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Nurses and Patient Navigators: Approval for nurses to receive CE has been applied for to the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996, to award up to 7.0 continuing education contact hours through the Florida Board of Nursing. FLASCO maintains responsibility for this program.

Pharmacists: This program is not yet approved for CME credit. CME credit has been applied for from Memorial Hospital. Total number of approved credits is yet to be determined. FLASCO maintains responsibility for this program.

This conference is proudly

co-sponsored by the following Companies:

2017 Corporate Members As of 6/27/2017

Diamond Elite Alexion Amgen Bristol-Myers Squibb Celgene Genentech BioOncology Merck Takeda Oncology Teva Pharmaceuticals

Diamond Astellas AstraZeneca Bayer Oncology Boehringer Ingelheim EMD Serono Lilly Oncology Pfizer Biosimilars Pfizer Oncology Sanofi Genzyme

Platinum AbbVie Adaptive Biotechnologies Biodesix Counsyl Eisai Exelixis Foundation Medicine Guardant Health Incyte INSYS Therapeutics J & J HealthCare Systems Kite Pharma Medivation Field Solutions Myriad Genetics NanoString Technologies Oncology Supply/ION Solutions Pharmacyclics Sandoz Seattle Genetics Taiho Oncology, Inc. Walgreens

Gold Biotheranostics Gilead Sciences IPSEN Biopharmaceuticals Merrimack Pharmaceuticals Novartis Oncology

Silver Clovis Oncology enterade® Helsinn Heron Therapeutics Invitae Kroger Specialty Pharmaceuticals Novocure Spectrum TESARO

FLASCO acknowledges the following companies as FLASCO Corporate Members

Page 4 of 4Page 4 of 4

Before or on Sept. 15, 2017 After Sept. 15, 2017

FLASCO Regular Members Complimentary $50.00

FLASCO Affiliate Members Complimentary $50.00

FLASCO Associate Members Complimentary $50.00

FLASCO Courtesy Members $100.00 $150.00

Non-FLASCO Members $250.00 $300.00

Registration is complimentary prior to September 15, 2017 for FLASCO Regular, Affiliate and Associate Members.

Reminder: To keep your complimentary membership active and in good standing, FLASCO members are encouraged to participate in at least one FLASCO or FLASCO co-sponsored event prior to December 31, 2018, or make a minimum contribution of $50 to FLASCO.

FLORIDA SOCIETY OF CLINICAL ONCOLOGY 10022 Water Works Lane │ Riverview, FL │ 33578 Phone: 813.677.0246 ext. 102 │ Fax: 813.677.0559

Email: Dorothy.Green@FLASCO.org

FLASCO reserves the right to alter this program without prior notice. Speakers and agenda are subject to change.

A block of rooms has been reserved at the

Renaissance Orlando at SeaWorld Hotel

6677 Sea Harbor Drive │ Orlando, Florida 32821

Reservations can be made by calling (407) 351-5555

Or clicking here. Please contact the hotel directly if room

arrangements are needed and mention your attendance to the

FLASCO Fall Session to receive the discounted rate of $169

plus applicable fees and taxes.

DEADLINES - The Renaissance Hotel has requested that all reservations be made

prior to September 15, 2017. After that date, reservations will only be accepted on

a space available and rate available basis.

HOTEL RESERVATIONS

The Florida Society of Clinical Oncology is a statewide non-profit

organization committed to facilitating and promoting multidisciplinary

efforts to improve patient care in Florida by:

Fostering access to quality cancer care to the citizens of Florida.

Assisting the cancer practitioners in providing the most cost effective quality care for

their patients.

Acting as an advocate for Florida cancer patients and their families.

Coordinating the dissemination of information and providing an opportunity for

oncologists, physicians, and other health care professionals to network and exchange

information on cancer care.

REGISTRATION & FEESREGISTRATION & FEES

FLASCO MISSION STATEMENT